Inaccurate Medication Coding in MDS Assessment
Summary
The facility failed to accurately assess a resident's medication regimen, specifically for Resident 29, during the Minimum Data Set (MDS) assessment. The significant change of status MDS with an Assessment Reference Date (ARD) of 02/08/2024 incorrectly marked Resident 29 for anticoagulant medication instead of antiplatelet medication. A review of the February 2024 Medication Administration Record (MAR) showed that Resident 29 received Brillanta, an antiplatelet medication, twice a day during the look-back period, but did not have an order for an anticoagulant medication. This discrepancy was identified during an interview and joint record review with the MDS Nurse, who acknowledged the error and stated that the MDS should have been marked for antiplatelet medication instead of anticoagulant medication. The Director of Nursing (DON) confirmed that the expectation was for the MDS to be completed accurately. The failure to correctly code the medication placed Resident 29 at risk for unidentified or unmet care needs and a diminished quality of life. The report references the Long-Term Care Resident Assessment Instrument (RAI) 3.0 User's Manual, which provides coding instructions for high-risk drug class medications based on their pharmacological classification. The facility's oversight in following these guidelines led to the inaccurate assessment of Resident 29's medication regimen.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.